Results 221 to 230 of about 101,624 (260)

Street Pharmacology: The Mechanistic Basis of Clinical Pharmacology Underlying the Microdosing Method of Buprenorphine-Naloxone With a Focus on the Unhoused Population. [PDF]

J Clin Pharmacol
Lehmann DF, Tanner O, Pepple E, Smith ZR, Ruiz-Salvador M.   +4 more
europepmc   +1 more source

Metal nanostructure‐coupled label‐free localized surface plasmon resonance biosensors for rapid and sensitive disease diagnosis

BMEMat, EarlyView.
LSPR biosensing enables rapid, sensitive, and low‐sample‐volume detection of biomarkers, with broad applications in diagnosing cancer, infectious, and chronic diseases. Advances in nanostructure design, micro/nanofabrication, and microfluidic integration have expanded the potential of LSPR sensors in biomedical diagnostics.
Zhaoxin Geng, Yunfei Sha, Jiongyan Yang, Hongru Yang, Xiao Liang   +4 more
wiley   +1 more source

PET Imaging of Accessible Prostate-Specific Membrane Antigen Reveals Dose-Dependent and Tumor Burden-Driven Variability. [PDF]

J Nucl Med
Mishra A, Lisok A, Mease RC, Nováková Z, Gupta K, Sharma AK, Pomper MG, Bařinka C, Nimmagadda S.   +8 more
europepmc   +1 more source

Bridging the translational gap in clinical nanomedicine: From rational design to clinical reality

BMEMat, EarlyView.
Nanotechnology offers a multi‐faceted approach to modern healthcare, encompassing high‐sensitivity diagnostic imaging, innovative vaccine delivery, and targeted therapeutics. This review explores how these nanomedicine applications address critical challenges in cancer recurrence and the treatment of neurologic and respiratory diseases to combat rising
Ahmed H. Ghonaim, Marwa Ahmed El‐Naka, Wedad M. Nageeb, Atta Ullah Khan, Noura M. Seleem, Aliaa Abdelghafar, Doaa Zamel, Yang Liu, Qigai He, Wentao Li   +9 more
wiley   +1 more source

Monoclonal Antibodies Directed Against IL-5 in the Treatment of Pediatric Asthma. [PDF]

Cells
Fainardi V, Carbone R, Buono EV, Menzella M, Caffarelli C.   +4 more
europepmc   +1 more source

Anticancer Peptides: Design Principles, Translational Bottlenecks, and Emerging Opportunities. [PDF]

Molecules
Di ME, Di YP.
europepmc   +1 more source

Viral Dynamic Model-Informed Dose Selection of Mosnodenvir Prophylaxis against DENV-3 in a Controlled Human Infection Model. [PDF]

Clin Pharmacol Ther
Goeyvaerts N, de Trixhe XW, Neyens M, Kakuda TN, Van Wesenbeeck L, Buelens A, Rasschaert F, Durbin A, Ackaert O.   +8 more
europepmc   +1 more source

New Personalized Medicine Model for Medication Management. [PDF]

J Pers Med
Alagiakrishnan K, Halverson T, Olivares DVF, Sadowski CA.   +3 more
europepmc   +1 more source